Progress against childhood cancer: The Pediatric Oncology Group experience

T. J. Vietti, V. Land, J. J. Shuster, M. Amylon, M. Link, C. Berard, W. Crist, M. Borowitz, J. Falletta, W. P. Bowman, M. Brecher, R. Castleberry, L. Frankel, A. Goorin, F. A. Hayes, E. Hvizdala, J. P. Krischer, B. H. Pollock, N. McWilliams

Resultado de la investigación: Articlerevisión exhaustiva

46 Citas (Scopus)


The sequential outcome was evaluated for all childhood cancers in which the Pediatric Oncology Group has conducted a series of clinical trials, with constant eligibility, on patients with newly diagnosed cancer. The analysis was applied to more than 7000 patients with cancer diagnosed between 1976 and 1989. These include acute leukemia (4 subgroups), non-Hodgkins lymphoma (4 subgroups), osteogenic sarcoma, and advanced neuroblastoma. In 8 of these 10 disease areas, significant improvement in outcome has occurred. In rare diseases such as pediatric cancer, collaborative studies may be the only way to conduct therapeutic trials of sufficient statistical power. A cooperative group has distinct advantages over a series of ad hoc collaborative studies in that it can maintain a unified data base, study its history with minimal confounding effects of changing institutional participants, and develop long- term research relationships among its participants.

Idioma originalEnglish (US)
Páginas (desde-hasta)597-600
Número de páginas4
EstadoPublished - 1992
Publicado de forma externa

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Profundice en los temas de investigación de 'Progress against childhood cancer: The Pediatric Oncology Group experience'. En conjunto forman una huella única.

Citar esto